490 related articles for article (PubMed ID: 30503931)
1. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
2. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
[TBL] [Abstract][Full Text] [Related]
3. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
7. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
8. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
Korhan P; Erdal E; Atabey N
Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
[TBL] [Abstract][Full Text] [Related]
10. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.
Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J
Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181a-5p enhances cell proliferation in medullary thymic epithelial cells via regulating TGF-β signaling.
Guo D; Ye Y; Qi J; Zhang L; Xu L; Tan X; Yu X; Liu Q; Liu J; Zhang Y; Ma Y; Li Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):840-9. PubMed ID: 27411504
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
15. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
16. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway.
Zhang J; Zhu Y; Hu L; Yan F; Chen J
Sci Rep; 2019 May; 9(1):7213. PubMed ID: 31076630
[TBL] [Abstract][Full Text] [Related]
17. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway.
Sun L; Guo Z; Sun J; Li J; Dong Z; Zhang Y; Chen J; Kan Q; Yu Z
Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
19. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
